Purdue Pharma faces more than 1,000 lawsuits claiming it ignited and fuelled the US opioid crisis, reports David Crow. Prosecutors say the company exaggerated the benefits of its painkiller OxyContin, but through their ownership of Rhodes Pharma, Purdue’s owners also have a far bigger market share than was realised.

Hosted on Acast. See acast.com/privacy for more information.